Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

328.87
Delayed Data
As of 4:02pm ET
 -9.12 / -2.70%
Today’s Change
201.91
Today|||52-Week Range
340.34
+27.76%
Year-to-Date

Today’s Trading

Previous close337.99
Today’s open337.08
Day’s range328.81 - 337.49
Volume2,765,977
Average volume (3 months)2,149,622
Market cap$132.6B
Dividend yield--
Data as of 4:02pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.36%
Earnings growth (next 5 years)+12.32%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.93+1.77%
NVONovo Nordisk-1.07-1.80%
ABBVAbbVie-0.61-0.86%
BMYBristol-Myers Squibb-0.43-0.66%
Data as of 4:04pm ET, 07/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$4.37
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts